Marine Complex Supplement Beneficial in Male Hair Thinning

This article originally appeared here.
Share this content:
Marine Complex Supplement Beneficial in Male Hair Thinning
Marine Complex Supplement Beneficial in Male Hair Thinning

THURSDAY, Aug. 25, 2016 (HealthDay News) -- A marine complex supplement is beneficial for men with thinning hair, according to a study published online Aug. 9 in the Journal of Cosmetic Dermatology.

Noting that an oral nutraceutical supplement based on a marine complex formation has been reported to increase the number of terminal hairs in women with thinning hair, Glynis Ablon, M.D., from the Ablon Skin Institute and Research Center in Manhattan Beach, Calif., confirmed the beneficial effects of a similar marine complex supplement in men with thinning hair. Healthy adult men with thinning hair were enrolled and randomly allocated to receive the study drug or placebo twice daily.

Ablon found that subjects indicated a significant improvement in three of six quality-of-life parameters at day 90, and a significant overall improvement in quality of life. Significant increases were seen for total hair count, total hair density, and terminal hair density after 180 days (all P < 0.001). Significant improvements were seen in terminal and vellus hair count and terminal hair density in investigator assessments. For study drug versus placebo, hair pull test results were significantly lower at days 90 (P < 0.05) and 180 (P < 0.01). No reports of treatment-emergent adverse events were observed.

"The results of this study showed for the first time that a dietary supplement containing a marine complex and other ingredients can decrease hair shedding and promote hair growth in men with thinning hair," Ablon writes.

The study was funded by Lifes2good, which manufactures the supplement used in the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »